Stay updated with breaking news from Pharma Analyst. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Covid-19 vaccination drive for children below the age of 18 might revive India's stuttering programme of mass inoculation of adolescents against other diseases
25 Jan 2022 Novavax continues to strengthen Asia presence with South Korea approval, says GlobalData Posted in Pharma American biotech... | January 25, 2022
Promising Atopic Dermatitis Treatment A major force in the atopic dermatitis (AD) space is Topical Janus kinase (JAK) inhibitors. Recently, an increasing number of JAK agents are filling the early and late-stage pipeline. Ramla Salad, Pharma Analyst at Global Data, comments "JAK inhibitors can combat AD at the immune system level due to their broad inhibitory effect. They are being developed in both oral and topical formulations, which target both mild-to-moderate and moderate-to-severe respectively". Thus, targeting an array of patient groups to tolerate the topical agents for mild-to-mode...
Search jobs Roche leads industry sponsored oncology trials in Australia, says GlobalData Australia has the highest age-standardized incidence rate for all cancers in the world and one of the countries with substantial cancer screening programs. Against this backdrop, several pharma companies are conducting clinical trials related to cancer drugs in the country. Among these, Roche continues to be a key player with the highest number of clinical trials in oncology indications, says GlobalData, a leading data and analytics company. Ms. Sasmitha Sahu, Pharma Analyst a...
Chinese COVID-19 vaccines crucial for developing nations: GlobalData Chinese COVID-19 vaccines crucial for developing nations: GlobalData 23 April 2021 | News China has so far provided COVID-19 vaccine aid to more than 50 developing nations and Sinovac Biotech alone has already supplied over 150 million doses to other countries Source credit: Shutterstock Beijing-based pharmaceutical company Sinovac Biotech’s CoronaVac vaccine was recently found to be 49.6 per cent effective in real-world data from Brazil. However, considering the global demand for COVID-19 vaccines and the supply-...